Sign In
×| Report | Interim | Year |
| Dallah’s net profit down 29.5% for 9M 2019 | 9 M | 2019 |
| Dallah H1 2019 profit drops 34% on higher OPEX | 6 M | 2019 |
| Dallah posts 39% profit decline in Q1 2019 | 3 M | 2019 |
| Dallah Healthcare posts 52% profit decline in FY18 | 12 M | 2018 |
Dallah Healthcare to pay H1 2019 dividend on Dec 5Argaam12/11/2019
A look at Dallah Health's expected results in Q4 2019Argaam Special21/01/2020
Aljazira Cap issues Q4 2019 earnings forecast for Tadawul-listed firmsArgaam Special07/01/2020
Al Rajhi Cap issues Q4 2019 earnings forecast for 31 listed firmsArgaam Special07/01/2020
Argaam Insight Reports
Market Data
| Last Trade | 47.85 |
| Change | (0.35) |
| Change (%) | (0.73) |
| Open | 48.15 |
| Low | 47.65 |
| High | 48.30 |
| Prev. Close | 48.20 |
| Change (3M) | 2.57 % |
| Change (6M) | (11.39 %) |
| Volume | 307,961 |
| Turnover | 14,770,276.00 |
| Transactions | 614 |
| Market Value | 3,588.75 |
| Avg. Volume (3M) | 198,386.09 |
| Avg. Turnover (3M) | 9,044,667.28 |
| Avg. Transaction (3M) | 423.86 |
| Change(12M) | (9.36 %) |
| YTD | 2.24 % |
| Current | |
| Market Cap (M Riyal) | 3,588.75 |
| Shares Outstanding ((M)) | 75.00 |
| EPS ( ) (TTM) | 1.46 |
| Book Value (BV) ( Riyal) (Latest announcement) | 19.85 |
| P/E ( Riyal) (TTM) | 32.75 |
| Price/book | 2.41 |
| Dividend Yield (%) (Last Year) | 2.47 |
| Return on Average Assets (%) (TTM) | 3.99 |
| Return on Average Equity (%) (TTM) | 7.09 |
| Enterprise Value (EV) (M) | 4,574.89 |
|
Event Date
|
Event
|
Venue
|
|
|---|---|---|---|
|
05-12-2019
|
Cash Dividend Distribution | - | |
|
28-11-2019
|
Ex-dividend Date | - | |
|
09-10-2019
|
General Assembly | - | |
|
01-05-2019
|
General Assembly | - | |
|
26-02-2019
|
General Assembly | - | |
| more | |||
| Date | Research firm | Rating | Target Price | Link |
|
|
Al Rajhi Capital | Overweight | 52.00 | |
|
|
AlJazira Capital | Neutral | 54.20 | |
|
|
Al Rajhi Capital | Neutral | 51.00 | |
|
|
AlJazira Capital | Neutral | 54.20 |
